Literature DB >> 29426605

Diversity of circulating tumor cells in peripheral blood: Detection of heterogeneous BRAF mutations in a patient with advanced melanoma by single-cell analysis.

Yukiko Kiniwa1, Kenta Nakamura1, Asuka Mikoshiba1, Yasuyuki Akiyama2, Atsushi Morimoto2, Ryuhei Okuyama3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29426605     DOI: 10.1016/j.jdermsci.2018.01.011

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  5 in total

Review 1.  Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives.

Authors:  Hisashi Kanemaru; Yukari Mizukami; Akira Kaneko; Ikko Kajihara; Satoshi Fukushima
Journal:  Curr Treat Options Oncol       Date:  2022-03-17

Review 2.  Single-Cell Analysis of Circulating Tumor Cells: Why Heterogeneity Matters.

Authors:  Su Bin Lim; Chwee Teck Lim; Wan-Teck Lim
Journal:  Cancers (Basel)       Date:  2019-10-19       Impact factor: 6.639

3.  Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.

Authors:  Yukiko Kiniwa; Kenta Nakamura; Asuka Mikoshiba; Atsuko Ashida; Yasuyuki Akiyama; Atsushi Morimoto; Ryuhei Okuyama
Journal:  BMC Cancer       Date:  2021-03-17       Impact factor: 4.430

4.  MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.

Authors:  Maria Cristina Rapanotti; Elisa Cugini; Marzia Nuccetelli; Alessandro Terrinoni; Cosimo Di Raimondo; Paolo Lombardo; Gaetana Costanza; Terenzio Cosio; Piero Rossi; Augusto Orlandi; Elena Campione; Sergio Bernardini; Marcel Blot-Chabaud; Luca Bianchi
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

Review 5.  Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma.

Authors:  Magali Boyer; Laure Cayrefourcq; Olivier Dereure; Laurent Meunier; Ondine Becquart; Catherine Alix-Panabières
Journal:  Cancers (Basel)       Date:  2020-04-13       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.